Suppr超能文献

血小板糖钙蛋白。I. 人血小板表面糖蛋白的取向

Platelet glycocalicin. I. Orientation of glycoproteins of the human platelet surface.

作者信息

Okumura T, Jamieson G A

出版信息

J Biol Chem. 1976 Oct 10;251(19):5944-9.

PMID:823154
Abstract

The orientation of proteins and glycoproteins of the platelet surface has been studied using various surface probes and labeling reagents. A fourth major glycoprotein has now been detected in platelet plasma membranes by sodium dodecyl sulfate-gel electrophoresis in addition to the previously recognized glycoproteins I, II, and III. Glycoprotein IV Mr, = approximately 87,000) appears to be present on the inner aspect of the membrane or buried within it since it is not accessible to surface probes such as lactoperoxidase-catalyzed iodination, radiolabeling with transglutaminase and [14C]glycine ethyl ester, or proteolytic enzymes. The ratio of these four major membrane-bound glycoproteins is approximately 10:4:2:3. Contrary to previous reports, only one glycoprotein, glycoprotein III, is accessible to lactoperoxidase-catalyzed iodination in intact platelets. Differences in the rate of destruction of glycoprotein II in intact platelets by trypsin suggests that two components may be migrating in this region. Examination of the soluble fraction obtained following platelet homogenization showed the presence of a single soluble glycoprotein of molecular weight 148,000 comprising about 10% of total platelet sialic acid. Treatment of intact platelets with neuraminidase resulted in the quantitative loss of siliac acid from the soluble glycoprotein, and it was strongly labeled in the intact platelet by [14C]glycine ethyl ester in the presence of transglutaminase. Treatment of intact platelets with chymotrypsin which does not cause the platelet release reaction, caused the rapid conversion of the soluble glycoprotein to a macroglycopeptide. These results indicate a surface origin for the soluble glycoprotein rather than a cytoplasmic or granular origin. The term glycocalicin is suggested for this glycoprotein in view of its origin in the platelet glycocalyx.

摘要

利用各种表面探针和标记试剂对血小板表面蛋白质和糖蛋白的取向进行了研究。除了先前识别出的糖蛋白I、II和III外,现在通过十二烷基硫酸钠-凝胶电泳在血小板质膜中检测到了第四种主要糖蛋白。糖蛋白IV(分子量约为87,000)似乎存在于膜的内侧或埋在膜内,因为它不能被诸如乳过氧化物酶催化碘化、用转谷氨酰胺酶和[14C]甘氨酸乙酯进行放射性标记或蛋白水解酶等表面探针所接触。这四种主要膜结合糖蛋白的比例约为10:4:2:3。与先前的报道相反,在完整血小板中,只有一种糖蛋白,即糖蛋白III,可被乳过氧化物酶催化碘化。胰蛋白酶对完整血小板中糖蛋白II的破坏速率差异表明,该区域可能有两种成分在迁移。对血小板匀浆后获得的可溶性部分的检查显示,存在一种分子量为148,000的单一可溶性糖蛋白,约占血小板总唾液酸的10%。用神经氨酸酶处理完整血小板会导致可溶性糖蛋白中的唾液酸定量损失,并且在转谷氨酰胺酶存在的情况下,它在完整血小板中被[14C]甘氨酸乙酯强烈标记。用不会引起血小板释放反应的胰凝乳蛋白酶处理完整血小板,会使可溶性糖蛋白迅速转化为大糖肽。这些结果表明可溶性糖蛋白起源于表面,而非细胞质或颗粒。鉴于其起源于血小板糖萼,建议将该糖蛋白称为糖萼素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验